MedWell Ai Executes Letter Of Intent To Create America's First Vertically Integrated Regenerative Wellness Eco-System

Company Overview - MedWell Ai, Inc has signed a Letter of Intent to establish a vertically integrated health, wellness, and longevity platform [1] - The new structure will consist of three core divisions: national pharma distribution and telemed platform, a portfolio of surgical and cosmetic centers, and an advanced biologics and product innovation group [2] Acquisitions and Financial Projections - The company plans to acquire and consolidate several entities, including Ageless Cosmetic Surgery Centers, Apollo BioWellness, and MedWell USA, which is currently generating revenues of $14 million in 2025 [3] - The consolidated company is projected to exceed $25 million in annual revenues for 2026, with conservative EBITDA margins of at least 20% [3] Strategic Goals and Management - The CEO of MedWell Ai emphasizes the goal of creating a comprehensive wellness ecosystem to enhance supply chain efficiency, quality control, and national expansion [5] - The company is also looking to bring in a seasoned management team to oversee the three verticals and is considering additional strategic acquisitions [5] Market Insights - The global regenerative medicine market was valued at approximately USD 35.5 billion in 2024 and is expected to grow to over USD 169 billion by 2034, with a CAGR of roughly 16% to 23% [7] - The broader global wellness economy reached USD 6.3 trillion in 2023 and is forecasted to reach USD 9.8 trillion by 2029 [7] - North America holds over 58% of the global market share in regenerative medicine, with the U.S. market projected to surpass USD 80 billion by 2033 [7]